Breaking News Instant updates and real-time market news.

ASND

Ascendis Pharma

$51.52

1.42 (2.83%)

04:55
02/13/18
02/13
04:55
02/13/18
04:55

Ascendis Pharma management to meet with JPMorgan

Meeting to be held in New York on February 13 hosted by JPMorgan.

  • 13

    Feb

ASND Ascendis Pharma
$51.52

1.42 (2.83%)

09/26/17
BOFA
09/26/17
NO CHANGE
Target $46
BOFA
Buy
BofA/Merrill ups Ascendis target to $46 after talking to physicians
BofA/Merrill analyst Tazeen Ahmad raised his price target on shares of Ascendis Pharma to $46 from $36 after speaking with two "expert" physicians who treat pediatric growth hormone deficiency. Feedback indicates U.S. doctors want to have access to multiple GHD treatment options, Ahmad tells investors in a research note. The analyst raised his peak worldwide penetration of the pediatric GHD market for Ascendis' Trans Con Growth Hormone to 27% from 25%. He believes TCGH is well positioned to be the first approved long-acting therapy for pediatric GHD and that Ascendis' pipeline could be undervalued. The analyst reiterates a Buy rating on the shares.
01/03/18
JPMS
01/03/18
NO CHANGE
JPMS
Overweight
JPMorgan sees 'compelling' entry point for Ascendis into data
JPMorgan analyst Jessica Fye believes shares of Ascendis Pharma at current levels offer a "compelling" entry point heading into initial readouts for TransCon PTH. The analyst sees TransCon PTH as an attractive program and expects initial data from the ongoing Phase I study at her firm's upcoming healthcare conference. 2018 is an important year for Ascendis to transition to a company with a pipeline of multiple orphan endocrinology assets, Fye tells investors in a research note. She keeps an Overweight rating on the shares with a $50 price target.
01/17/18
JPMS
01/17/18
NO CHANGE
Target $60
JPMS
Overweight
Ascendis Pharma price target raised to $60 from $50 at JPMorgan
JPMorgan analyst Jessica Fye raised her price target for Ascendis Pharma to $60 citing the "clearly positive" initial phase I single ascending dose data for TransCon PTH reported last week. The data reinforce both the product's potential profile in hypoparathyroidism and the broader potential of the TransCon platform to improve both the efficacy and safety of parent molecules with lower clinical development risk, Fye tells investors in a research note. The analyst reiterates an Overweight rating on Ascendis.
01/25/18
BOFA
01/25/18
NO CHANGE
Target $60
BOFA
Buy
Ascendis Pharma price target raised to $60 from $45 at BofA/Merrill
BofA/Merrill analyst Tazeen Ahmad raised Ascendis Pharma's price target to $60 from $45 following the recent TransCon PTH update saying, if approved, the company's Phase 3 program in pediatric growth hormone deficiency could address an area of unmet need given once weekly dosing versus current therapies that are once per day. Ahmad rates Ascendis a Buy.

TODAY'S FREE FLY STORIES

OSTK

Overstock.com

$64.15

-2.95 (-4.40%)

12:45
02/20/18
02/20
12:45
02/20/18
12:45
Options
Overstock com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
02/20/18
02/20
12:45
02/20/18
12:45
General news
Treasury 2-year auction preview: the auction could see ok results »

Treasury 2-year auction…

MDXG

MiMedx

$14.47

-0.96 (-6.22%)

12:43
02/20/18
02/20
12:43
02/20/18
12:43
Recommendations
MiMedx analyst commentary  »

Piper Jaffray…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

AGII

Argo Group

$60.50

-0.1 (-0.17%)

12:37
02/20/18
02/20
12:37
02/20/18
12:37
Hot Stocks
Argo Group announces 15% stock dividend, 27c per share cash dividend »

Argo Group International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBI

CB&I

$19.09

0.38 (2.03%)

12:35
02/20/18
02/20
12:35
02/20/18
12:35
Options
CB&I put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
02/20/18
02/20
12:35
02/20/18
12:35
General news
Treasury Option Action: call buying in the belly has grown »

Treasury Option Action:…

TM

Toyota

$136.51

0.31 (0.23%)

12:33
02/20/18
02/20
12:33
02/20/18
12:33
Hot Stocks
Toyota recalls some Sequoia and Tundra vehicles »

Toyota Motor North…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZNGA

Zynga

$3.59

0.02 (0.56%)

12:30
02/20/18
02/20
12:30
02/20/18
12:30
Conference/Events
Zynga management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 26

    Feb

12:28
02/20/18
02/20
12:28
02/20/18
12:28
Conference/Events
Cantor analysts to hold an analyst/industry conference call »

Analysts, along with…

QTNA

Quantenna Communications

$14.10

0.01 (0.07%)

12:27
02/20/18
02/20
12:27
02/20/18
12:27
Conference/Events
Quantenna Communications management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 22

    Feb

  • 26

    Feb

  • 11

    Mar

BHP

BHP Billiton

$46.62

-2.07 (-4.25%)

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Downgrade
BHP Billiton rating change  »

BHP Billiton downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QNTA

Quanta Capital Hldgs

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Conference/Events
Quanta Capital Hldgs management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$22.68

-0.06 (-0.26%)

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Options
Marvell call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 08

    Mar

MRVL

Marvell

$22.68

-0.06 (-0.26%)

, CAVM

Cavium

$87.16

-0.09 (-0.10%)

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Conference/Events
Cavium to host special shareholder meeting »

Special Shareholder…

MRVL

Marvell

$22.68

-0.06 (-0.26%)

CAVM

Cavium

$87.16

-0.09 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 08

    Mar

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Conference/Events
UBS airlines analyst holds an analyst/industry conference call »

Analyst Genovesi, along…

SCI

Service Corp.

$38.65

-0.2 (-0.51%)

12:25
02/20/18
02/20
12:25
02/20/18
12:25
Conference/Events
Service Corp. to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 26

    Feb

  • 04

    Mar

WMT

Walmart

$95.22

-9.56 (-9.12%)

12:21
02/20/18
02/20
12:21
02/20/18
12:21
Recommendations
Walmart analyst commentary  »

Walmart e-commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 28

    Feb

  • 07

    Mar

  • 18

    Mar

WMT

Walmart

$95.23

-9.55 (-9.11%)

, HD

Home Depot

$189.64

2.67 (1.43%)

12:17
02/20/18
02/20
12:17
02/20/18
12:17
General news
On The Fly: Top stock stories at midday »

Stocks opened deep in…

WMT

Walmart

$95.23

-9.55 (-9.11%)

HD

Home Depot

$189.64

2.67 (1.43%)

NXPI

NXP Semiconductors

$118.50

1.58 (1.35%)

QCOM

Qualcomm

$64.85

-0.43 (-0.66%)

AVGO

Broadcom

$248.89

-2.94 (-1.17%)

RAD

Rite Aid

$2.21

0.0801 (3.76%)

MDXG

MiMedx

$14.47

-0.96 (-6.22%)

UBNT

Ubiquiti

$74.04

-1.25 (-1.66%)

VYGR

Voyager Therapeutics

$19.36

0.19 (0.99%)

ABBV

AbbVie

$120.79

2.19 (1.85%)

FOGO

Fogo De Chao

$12.55

-0.15 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 25

    Feb

  • 28

    Feb

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 14

    Mar

  • 18

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

  • 30

    May

$NSD

NASDAQ Market Internals

12:17
02/20/18
02/20
12:17
02/20/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
02/20/18
02/20
12:16
02/20/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALE

Vale

$14.23

0.105 (0.74%)

12:15
02/20/18
02/20
12:15
02/20/18
12:15
Options
Vale put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFII

Electronics for Imaging

$28.11

0.04 (0.14%)

12:10
02/20/18
02/20
12:10
02/20/18
12:10
Conference/Events
Electronics for Imaging management to meet with Loop Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 13

    Mar

  • 14

    Mar

BHP

BHP Billiton

$46.89

-1.8 (-3.70%)

12:09
02/20/18
02/20
12:09
02/20/18
12:09
Downgrade
BHP Billiton rating change  »

BHP Billiton downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$41.63

-0.51 (-1.21%)

12:05
02/20/18
02/20
12:05
02/20/18
12:05
Options
Mylan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 13

    Nov

12:05
02/20/18
02/20
12:05
02/20/18
12:05
General news
Euro$ interest rate futures are mostly lower »

Euro$ interest rate…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.